New model would be used to analyze biopsies of salivary glands Using artificial intelligence (AI) to analyze biopsies of the salivary glands in people with Sjögren’s disease may help identify patients who are likely to have disease involvement in vital organs, a new study reports. According to the researchers, the novel model developed by the
Diagnostic Imaging’s Weekly Scan: June 22 — June 28
By Diagnostic Imaging Staff
News
Slideshow
Diagnostic Imaging’s Weekly Scan is your chance to catch up on the latest radiology content, from new research and device news to the latest conference reports. Review the slideshow below to see this week’s top content:
Recent Videos
Related Content
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
Jeff Hall
June 27th 2025
Article
While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
The Reading Room Podcast: Current Insights on Recent Research About Radiation-Induced Cancers with CT Scans, Part 2
Jeff Hall
May 5th 2025
Podcast
In a second part of a new podcast episode on recently published research on projected radiation-induced cancers from computed tomography (CT) scans, Mahadevappa Mahesh, MS, Ph.D., and Joseph Cavallo, M.D., offer current perspectives on cardiac CT dosing, AI advances and the importance of teamwork in ensuring appropriate dosing for CT.
New Study Examines Key Factors with False Negatives on AI Mammography Analysis
Jeff Hall
June 25th 2025
Article
Artificial intelligence (AI) software had a 14 percent false negative rate in a new study involving over 1,082 women with invasive breast cancer.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
Jeff Hall
March 18th 2025
Podcast
In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
FDA Grants Expanded Approval for Illuccix in Patient Selection for Pre-Taxane Radioligand Therapy
Jeff Hall
June 24th 2025
Article
The additional indication for the preparation kit of gallium Ga-68 gozetotide may facilitate earlier use of PSMA-targeted treatment for men with prostate cancer.
FDA Clears AI-Powered Fetal Ultrasound Analysis Software from DeepEcho
Jeff Hall
June 20th 2025
Article
The AI software reportedly facilitates ease of use and improved accuracy in fetal ultrasound evaluations.
Related Content
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
Jeff Hall
June 27th 2025
Article
While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
The Reading Room Podcast: Current Insights on Recent Research About Radiation-Induced Cancers with CT Scans, Part 2
Jeff Hall
May 5th 2025
Podcast
In a second part of a new podcast episode on recently published research on projected radiation-induced cancers from computed tomography (CT) scans, Mahadevappa Mahesh, MS, Ph.D., and Joseph Cavallo, M.D., offer current perspectives on cardiac CT dosing, AI advances and the importance of teamwork in ensuring appropriate dosing for CT.
New Study Examines Key Factors with False Negatives on AI Mammography Analysis
Jeff Hall
June 25th 2025
Article
Artificial intelligence (AI) software had a 14 percent false negative rate in a new study involving over 1,082 women with invasive breast cancer.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
Jeff Hall
March 18th 2025
Podcast
In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
FDA Grants Expanded Approval for Illuccix in Patient Selection for Pre-Taxane Radioligand Therapy
Jeff Hall
June 24th 2025
Article
The additional indication for the preparation kit of gallium Ga-68 gozetotide may facilitate earlier use of PSMA-targeted treatment for men with prostate cancer.
FDA Clears AI-Powered Fetal Ultrasound Analysis Software from DeepEcho
Jeff Hall
June 20th 2025
Article
The AI software reportedly facilitates ease of use and improved accuracy in fetal ultrasound evaluations.
Related Posts
